Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023 - Takeaways - MDSpire

Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023

  • By

  • Ziyue Wang

  • Shuai Wang

  • Guomu Liu

  • Hao Wu

  • Yuguo Chen

  • July 15, 2026

Share

  • 1

    In 2023, China reported 118,381 incident cases and 114,949 deaths from pancreatic cancer, highlighting its significant public health burden.

  • 2

    The age-standardized prevalence rate of pancreatic cancer increased slightly, with a reported average annual percentage change of 0.38%.

  • 3

    High fasting plasma glucose was identified as a more significant risk factor for pancreatic cancer burden than smoking in China.

  • 4

    The burden of pancreatic cancer was consistently higher in males compared to females, with rising incidence rates in younger and older age groups.

  • 5

    Population aging was a major contributor to the increasing burden of pancreatic cancer in China from 1990 to 2023.

Original Source(s)

Pancreatic cancer burden in China from 1990 to 2023: an analysis based on the global burden of disease study 2023

  • by Ziyue Wang, Shuai Wang, Guomu Liu, Hao Wu, Yuguo Chen

  • July 15, 2026

Related Content

Research progress of small molecule targeted drugs for non-small cell lung cancer

Sarcopenia in breast cancer: prognostic values and emerging therapeutic strategies

Diversion ostomy improves treatment tolerance, conversion surgery, and survival compared with self-expanding metal stenting in initially unresectable obstructive colorectal cancer